Prepare for your visit

James C Vestal

Urology · Arlington, TX · NPI 1770579161

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$290,170.67

in general payments reported to CMS, 2019-2025 · $78K in 2025

The $78K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).

Who reported paying

General payments only, top 6 by amount.

Janssen Biotech, INC. $178,299.08
Bayer Healthcare Pharmaceuticals INC. $32,187.21
Genzyme Corporation $24,680.17
Astrazeneca Pharmaceuticals LP $14,145.15
Dendreon Pharmaceuticals LLC $8,912.52
Ferring Pharmaceuticals INC. $6,173.47

Drugs and devices associated with these payments

Erleada Carvykti Rybrevant Nubeqa Akeega Imfinzi Provenge Adstiladrin Padcev Lynparza Truqap Jelmyto

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw James Vestal listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/79957/james-c-vestal